Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ovarian Neoplasms

  Free Subscription


1 Am J Obstet Gynecol
2 BMC Cancer
1 Eur J Obstet Gynecol Reprod Biol
5 Gynecol Oncol
1 Int J Cancer
2 Int J Gynaecol Obstet
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Obstet Gynecol

  1. MARCHAND G, Mills K, Ware K
    Reply to a question regarding ovarian cancer prevention with partial salpingectomy versus complete.
    Am J Obstet Gynecol. 2021 Jun 30. pii: S0002-9378(21)00769.

    BMC Cancer

  2. LI Y, Jaiswal SK, Kaur R, Alsaadi D, et al
    Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.
    BMC Cancer. 2021;21:768.
    PubMed         Abstract available

  3. HE X, Wei L, Li R, Jing S, et al
    Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: a retrospective study.
    BMC Cancer. 2021;21:738.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  4. KANNEGANTI A, Bhadiraju P, Tong PSY
    Extragonadal teratomas in women and adolescent girls: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:134-141.
    PubMed         Abstract available

    Gynecol Oncol

  5. PHILP L, Tannenbaum S, Haber H, Saini A, et al
    Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
    Gynecol Oncol. 2020 Dec 23. pii: S0090-8258(20)34174.
    PubMed         Abstract available

  6. O'TOOLE SA, Huang Y, Norris L, Power Foley M, et al
    HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    Gynecol Oncol. 2020 Nov 16. pii: S0090-8258(20)34112.
    PubMed         Abstract available

  7. SAFRA T, Waissengrin B, Gerber D, Bernstein-Molho R, et al
    Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.
    Gynecol Oncol. 2021 Jun 22. pii: S0090-8258(21)00489.
    PubMed         Abstract available

  8. CHO A, Lee SW, Park JY, Kim DY, et al
    Continued medical treatment for persistent early endometrial cancer in young women.
    Gynecol Oncol. 2020 Nov 24. pii: S0090-8258(20)34115.
    PubMed         Abstract available

  9. GOTOH O, Kiyotani K, Chiba T, Sugiyama Y, et al
    Immunogenomic landscape of gynecologic carcinosarcoma.
    Gynecol Oncol. 2020 Dec 6. pii: S0090-8258(20)34158.
    PubMed         Abstract available

    Int J Cancer

  10. COUGHLAN AY, Testa G
    Exploiting epigenetic dependencies in ovarian cancer therapy.
    Int J Cancer. 2021 Jul 2. doi: 10.1002/ijc.33727.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  11. LI S, Li H, Tian S, Wu J, et al
    Association between ovarian and breast masses among Chinese women in Chongqing based on ultrasonography screening: A cross-sectional study.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13568.
    PubMed         Abstract available

  12. KIM SR, Maganti M, Bernardini MQ, Laframboise S, et al
    Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer.
    Int J Gynaecol Obstet. 2021 Jul 2. doi: 10.1002/ijgo.13813.
    PubMed         Abstract available

    Oncol Rep

  13. WEN J, Han S, Cui M, Wang Y, et al
    [Retracted] Long noncoding RNA MCM3APAS1 drives ovarian cancer progression via the microRNA1433p/TAK1 axis.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.